Sector dividends Charles River Laboratories International, Inc.
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
NYSE
23:00:02 10/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 273.00 USD | -1.92% |
|
-6.94% | +36.86% |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -.--% | -.--% | 74.46x | 4.41x | 3.94x | 15.27x | 18.76x | 13.29B | ||
| 1.03% | 1.19% | 31.44x | 4.2x | 5.66x | 16.96x | 23.73x | 46.38B | ||
| -.--% | -.--% | -21.25x | 21.95x | 245.77x | -22.82x | -21.53x | 44.51B | ||
| -.--% | -.--% | 33.09x | 6.04x | 3.22x | 13.91x | 21.02x | 42.3B | ||
| -.--% | -.--% | 45.98x | 7.78x | 5.31x | 29.05x | 33.43x | 39.91B | ||
| 0.41% | 0.45% | 27.78x | 2.25x | 8.36x | 21.2x | 25.17x | 32.79B | ||
| -.--% | -.--% | 33.34x | 23.92x | 5.46x | 24.79x | 25.94x | 16.36B | ||
| 1.13% | 1.28% | 23.65x | 2.63x | 2.07x | 8.96x | 13.89x | 14.31B | ||
| -.--% | -.--% | 27.08x | 1.28x | 1.8x | 11.04x | 12.58x | 12.31B | ||
| 0.44% | 0.44% | 52.29x | 4.56x | 8.68x | 24.63x | 29.38x | 11.33B | ||
| -.--% | -.--% | -44x | 22.05x | 7.31x | 178.75x | -1620.07x | 11.06B | ||
| 0.58% | 0.73% | 38.42x | 4.42x | 4.54x | 19.42x | 31.22x | 10.49B | ||
| -.--% | -.--% | -28.54x | 8.4x | 103.07x | -28.95x | -47.89x | 10.25B | ||
| -.--% | -.--% | -24.86x | 8.59x | 10367.92x | -20.48x | -20.17x | 9.64B | ||
| -.--% | -.--% | -29.81x | 8.67x | 78.78x | -19.86x | -19.26x | 9.6B | ||
| -.--% | -.--% | -359.1x | 2.35x | 10.56x | 62.75x | 82.1x | 9.39B | ||
| -.--% | -.--% | 31.2x | - | 16.32x | 29.78x | 29.1x | 9.39B | ||
| -.--% | -.--% | -15.42x | 648.53x | 10.09x | -16.19x | -15.62x | 9.31B | ||
| 0.32% | 0.43% | 22.06x | 2.35x | 4.42x | 11.88x | 15.15x | 8.79B | ||
| Average | 0.21% | 0.24% | -4.33x | 43.58x | 573.33x | 18.95x | -72.79x | 19.02B | |
| Weighted average by Cap. | 0.25% | 0.29% | 9.76x | 25.54x | 316.53x | 15.73x | -35.62x |
Select your edition
All financial news and data tailored to specific country editions
















